Recent advances in the development of dopamine D(3) receptor agonists and antagonists.

Mini reviews in medicinal chemistry

Volumn 1, Issue 1, 2001, Pages 89-99

  Crider, A M ^a   Scheideler, M A ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DRD3 PROTEIN, HUMAN; LIGAND; NEUROLEPTIC AGENT;

ANIMAL; CHEMISTRY; DRUG DESIGN; DRUG EFFECT; HUMAN; PHYSIOLOGY; REVIEW; SCHIZOPHRENIA; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANIMALS; ANTIPSYCHOTIC AGENTS; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DRUG DESIGN; HUMANS; LIGANDS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SCHIZOPHRENIA; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0035352417     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389557013407287     Document Type: Review

References (71)